聖湘生物(688289.SH):取得人乳頭瘤病毒核酸分型檢測試劑盒(PCR-熒光探針法)的醫療器械註冊證
格隆匯8月4日丨聖湘生物(688289.SH)公佈,公司的產品人乳頭瘤病毒核酸分型檢測試劑盒(PCR-熒光探針法)於近日收到由國家藥品監督管理局頒發的《醫療器械註冊證》。
人乳頭瘤病毒核酸分型檢測試劑盒(PCR-熒光探針法)採用多重熒光PCR技術,可用於體外定性檢測女性宮頸脱落上皮細胞樣本中的人乳頭瘤病毒(HPV)6型、11型、16型、18型、26型、31型、33型、35型、39型、42型、43型、45型、51型、52型、53型、56型、58型、59型、66型、68型、73型、81型、82型這23種型別的核酸DNA,並鑑別基因型。該產品的推出完善了聖湘生物在HPVDNA檢測領域的產品矩陣,為高效、精準、可及的聖湘生物HPV全場景解決方案添上重要一筆,持續助力婦幼健康。
上述產品取得醫療器械註冊證,有利於豐富公司的產品種類,擴充公司在分子診斷領域的產品佈局,不斷滿足多元化的市場需求,進一步增強公司的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.